Literature DB >> 26140056

Innovative Clinical Trial Designs: Toward a 21st-Century Health Care System.

Tze L Lai1, Philip W Lavori2.   

Abstract

Whereas the 20th-century health care system sometimes seemed to be inhospitable to and unmoved by experimental research, its inefficiency and unaffordability have led to reforms that foreshadow a new health care system. We point out certain opportunities and transformational needs for innovations in study design offered by the 21st-century health care system, and describe some innovative clinical trial designs and novel design methods to address these needs and challenges.

Entities:  

Keywords:  Cancer clinical trials; Comparative effectiveness research; Embedded experiments; Personalized therapies; Sequential design and randomization

Year:  2011        PMID: 26140056      PMCID: PMC4485389          DOI: 10.1007/s12561-011-9042-5

Source DB:  PubMed          Journal:  Stat Biosci        ISSN: 1867-1764


  81 in total

1.  On the limitations of comparative effectiveness research.

Authors:  Donald B Rubin
Journal:  Stat Med       Date:  2010-08-30       Impact factor: 2.373

2.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

3.  Development and validation of therapeutically relevant multi-gene biomarker classifiers.

Authors:  Richard Simon
Journal:  J Natl Cancer Inst       Date:  2005-06-15       Impact factor: 13.506

4.  Statistical methods for analyzing sequentially randomized trials.

Authors:  Oliver Bembom; Mark J van der Laan
Journal:  J Natl Cancer Inst       Date:  2007-10-30       Impact factor: 13.506

5.  Sequential causal inference: application to randomized trials of adaptive treatment strategies.

Authors:  Ree Dawson; Philip W Lavori
Journal:  Stat Med       Date:  2008-05-10       Impact factor: 2.373

6.  A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.

Authors:  P F Thall; K E Russell
Journal:  Biometrics       Date:  1998-03       Impact factor: 2.571

7.  Behavioral contingencies improve counseling attendance in an adaptive treatment model.

Authors:  Robert K Brooner; Michael S Kidorf; Van L King; Kenneth B Stoller; Jessica M Peirce; George E Bigelow; Ken Kolodner
Journal:  J Subst Abuse Treat       Date:  2004-10

8.  Patient-specific dose finding based on bivariate outcomes and covariates.

Authors:  Peter F Thall; Hoang Q Nguyen; Elihu H Estey
Journal:  Biometrics       Date:  2008-03-19       Impact factor: 2.571

Review 9.  Clinical trial designs for targeted agents.

Authors:  Brigette B Y Ma; Carolyn D Britten; Lillian L Siu
Journal:  Hematol Oncol Clin North Am       Date:  2002-10       Impact factor: 3.722

10.  Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.

Authors:  Peter F Thall; Christopher Logothetis; Lance C Pagliaro; Sijin Wen; Melissa A Brown; Dallas Williams; Randall E Millikan
Journal:  J Natl Cancer Inst       Date:  2007-10-30       Impact factor: 13.506

View more
  4 in total

1.  EFFICACY-TO-EFFECTIVENESS CLINICAL TRIALS.

Authors:  Harry P Selker; Sheeona Gorman; Kenneth I Kaitin
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

Review 2.  Innovative designs of point-of-care comparative effectiveness trials.

Authors:  Mei-Chiung Shih; Mintu Turakhia; Tze Leung Lai
Journal:  Contemp Clin Trials       Date:  2015-06-19       Impact factor: 2.226

3.  Adjusting for misclassification in a stratified biomarker clinical trial.

Authors:  Chunling Liu; Aiyi Liu; Jiang Hu; Vivian Yuan; Susan Halabi
Journal:  Stat Med       Date:  2014-04-14       Impact factor: 2.373

Review 4.  Managing Expectations in the Transition to Proof of Concept Studies.

Authors:  Thomas Kieber-Emmons; Issam Makhoul; Angela Pennisi; Eric R Siegel; Peter D Emanuel; Bejotaloh Monzavi-Karbassi; Zenon Steplewski; J Thaddeus Beck; Laura F Hutchins
Journal:  Rev Recent Clin Trials       Date:  2017
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.